male
Happy New Year to you also.
As Fox News would say we need fair and balanced reporting and factual contributors observing industry trends in this market place for this product eo
We need the pros and cons about this stock since the
company has gotten FDA and EU approval the stock has
gone the other way.
We need to understand reasons why we are languishing at $.30 per share when prior
to FDA approval we were over $2.
The company has a great product but has been relatively slow
in getting this across the plate in timely execution and it has been 5 months since approvals.
Bases are are loaded now they have FDA and EU approval
approval,manufacturing,inventory build up and a international sales manager to handle the distribution channels and
joint ventures
We need lift off now in the form of financing,distribution sales and market awareness at the investor level,surgeon level
and patient level
Thus far,the company has fell far short in acheiving these goals by playing this close to the vest
I am sure this has caused the weak hands to sell their stock
You tend to perceive as my questions as negative when
I ask for opinions about where company is headed since their approvals and any new developments that will affect the price of this stock
They have not gained any traction in sales or a joint venture meanwhile this lack of progress has resulted in selling and the stock being where it is
Hopefully the time is now at hand the first quarter of 2009
that the company has promised to launch and hopefully they
have the wherewithall to execute.
It is now show me time,if not the market opportunity may drift awayand go to the majors or some other well financed company and we will stay where we are now
bbhuey
w
